Drupal.behaviors.print = function(context) {window.print();window.close();}>
Agilent Registers Facility with FDA as Medical Device Establishment
June 27, 2011
Agilent Registers Facility with FDA as Medical Device Establishment
The registration signals Agilent's intent to develop diagnostic products.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
FDA Approves Dako Assays as CDx for Genentech Breast Cancer Drug
March 5, 2013 / GenomeWeb Daily News
FDA Approves Dako's HER2 IQFISH Assay
February 15, 2013 / GenomeWeb Daily News
Agilent Lists LCs, Mass Specs as Class I Devices with FDA
January 17, 2012 / GenomeWeb Daily News
Lab Group to Ask Congress for Statutory Changes to Keep LDTs Under CLIA
May 4, 2011 / Pharmacogenomics Reporter
FDA Warned Millipore on H1N1 Test Marketing
February 2, 2010 / GenomeWeb Daily News